However, the association between PIK3CA mutations and HER2-positive BC is still unclear, since previous analyses have either correlated PIK3CA mutations with favorable clinical outcomes or found no significant impact [16,17,20,21,22,23,24,25,26]. This evidence concerns the gene PIK3CA and breast cancer.